EECP Therapy a good practice investment?
This article was written by an anonymous investor in 2003 about EECP Therapy.
September 23, 2003
There is always skepticism when looking at new investments to bring into a medical facility.
Most often, people will ask the following questions:
1. Will this investment be safe for my patients?
2. Does it have clinical viability and effective with my patients?
3. Will this investment generate substantial revenue to my practice?
4. What are the costs? Do they exceed the feasible revenue?
5. What are the burdens to my staff and facility?
6. What kind of burden will this investment put on the physicians?
7. What kind of time does it take to break even?
8. Is this investment susceptible to market changes?
9. Are there any significant risks or liabilities associated with this investment opportunity?
Now lets analyze how External Counterpulsation Therapy (ECP Therapy and EECP Therapy) fits the proposed question analysis.
1. Will this investment be safe for my patients?
EECP is considered to be very safe and tolerable for patients. This is one of the best features of EECP!
2. Does it have clinical viability with my patients?
EECP Therapy has been proven in more than 140 clinical trials to benefits nearly 80% of patients that complete treatment.
3. Will this investment generate substantial revenue to my practice?
EECP generates one of the highest reimbursements per patient than any other outpatient procedure in a Cardiology facility.
4. What are the costs? Do they exceed the feasible revenue?
EECP device costs have come down by nearly 60% since 2005.
5. What are the burdens to my staff and facility?
EECP is proven to be an simple modality that virtually any office staff member can administer.
6. What kind of burden will this investment put on the physicians?
EECP requires NO time for the referring or supervising physician.
7. What kind of time does it take to break even?
EECP reimbursement from Medicare is $4800 as a national average. The breakeven point varies depending on the price for the ECP or EECP machine but it can be as soon as 5 patients!
8. Is this investment susceptible to market changes?
All investments are susceptible to some changes but EECP therapy has been proven to save Medicare and Private Insurance money compared to other treatments for angina.
9. Are there any significant risks or liabilities associated with this investment opportunity
EECP is one of the safest investment both clinically and financially for a medical facility. Most patients qualify for treatment and there has been few complications from EECP.
For more information, visit Candidates for ECP Therapy
